News
Bitcoin’s ( BTC) status as a haven in the context of broader financial markets may be up for debate, but within crypto it’s ...
CD20 × CD3 bispecific antibodies bind to both CD20 on malignant B cells and CD3 on T cells, bringing them into close proximity, which triggers T cell-mediated killing of the targeted B cells.
Equipped with a 3D super-resolution microscopy technique, Sauer and his team set out to investigate how mAbs bind to the B cell surface receptor CD20, a common immunotherapy target for some blood ...
The results from the first human trial of ocrelizumab, a humanized anti-CD20 monoclonal antibody, in the treatment of rheumatoid arthritis (RA) have recently been presented. Genovese et al.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results